Gboxin
Gboxin is an oxidative phosphorylation (OXPHOS) inhibitor that targets glioblastoma. Gboxin inhibits the activity of F0F1 ATP synthase. Antitumour activity[1].
Product Specifications
CAS Number
2101315-36-8
UNSPSC
12352005
Target
ATP Synthase; Mitochondrial Metabolism; Oxidative Phosphorylation
Type
Reference compound
Related Pathways
Membrane Transporter/Ion Channel; Metabolic Enzyme/Protease
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/Gboxin.html
Concentration
10mM
Purity
98.23
Solubility
DMSO : 32.5 mg/mL (ultrasonic) |H2O : 10 mg/mL (ultrasonic)
Smiles
O=C(O[C@H]1[C@H](C(C)C)CC[C@@H](C)C1)CN2C(CC)=[N+](C)C3=CC=CC=C23.[Cl-]
Molecular Formula
C22H33ClN2O2
Molecular Weight
392.96
References & Citations
[1]Shi Y, et al. Gboxin is an oxidative phosphorylation inhibitor that targets glioblastoma. Nature. 2019 Mar;567 (7748) :341-346.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Alkaline Phosphatase Conjugated Phaseolus vulgaris Lectin (Red Kidney Bean) -PHA-E-
Creatine kinase M type (CKM) (NM_001824) Human Over-expression Lysate
p-Nitrobenzyl 6-(1’-Hydroxyethyl)-azabicyclo(3.2.0)heptane-3,7-dione-2-carboxylate
